Waystar Holding Corp. reported first‑quarter 2026 revenue of $313.9 million, a 22% year‑over‑year increase, and net income of $43.3 million. Adjusted earnings per share were $0.42, beating consensus estimates of $0.39 and underscoring the company’s ability to generate profit while expanding its top line.
Revenue was largely in line with expectations. The company’s $313.9 million figure fell slightly short of the higher consensus estimate of $314.5 million but surpassed the lower estimate of $312.4 million. The modest miss reflects a small shortfall in the high‑margin provider‑solutions segment, offset by stronger performance in the patient‑payment segment, which grew faster than expected.
Waystar’s gross revenue retention was reported at 97% and net revenue retention at 111%, indicating that existing customers are not only staying but also expanding their spend. Adjusted EBITDA margin expanded to 43% from 41% in the prior year, driven by a higher mix of high‑margin AI‑enabled contracts and improved operational leverage as the platform scales. The company’s AI initiatives—such as the recoupment tool and Prebill Anomaly Detection—have begun to generate incremental revenue and improve margin profiles.
Management reaffirmed its full‑year 2026 guidance, projecting revenue of $1.274 billion to $1.294 billion and adjusted EPS of $1.59 to $1.68. The unchanged outlook signals confidence that the company’s growth trajectory will continue, supported by the ongoing integration of the $1.25 billion Iodine Software acquisition and the expansion of its AI‑powered platform.
Compared with the prior quarter, Q1 2026 revenue grew 3.4% from $303.5 million in Q4 2025, while net income rose 48% from $29.3 million in Q1 2025. The company’s higher‑margin provider‑solutions segment grew 12% YoY, whereas the patient‑payment segment grew 8% YoY, reflecting a favorable mix shift. Headwinds include patient‑payment headwinds from digital statement adoption and insurance changes, but tailwinds such as AI adoption and the Iodine integration are expected to offset these pressures.
Investors reacted cautiously to the results. The slight revenue miss against the higher consensus estimate and the fact that the revenue and adjusted EBITDA beats were the lowest in seven quarters tempered enthusiasm, even as the company’s strong earnings beat and margin expansion reinforced confidence in its execution strategy.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.